1054 related articles for article (PubMed ID: 29945519)
1. Reply to E.L. Pollom et al, N. Ohri et al, A. Fiorentino et al, D.R. Wahl et al, N. Kim et al, J. Boda-Heggemann et al, S. Rana et al, N. Sanuki et al, J.R. Olsen et al, G.L. Smith et al, and A. Shinde et al.
Rajyaguru DJ; Borgert AJ; Halfdanarson TR; Truty MJ; Kurup AN; Go RS
J Clin Oncol; 2018 Aug; 36(24):2567-2569. PubMed ID: 29945519
[No Abstract] [Full Text] [Related]
2. Correspondence on Rajyaguru et al.
Boda-Heggemann J; Gkika E; Andratschke N; Blanck O; Guckenberger M; Lohr F; Brunner TB
J Clin Oncol; 2018 Aug; 36(24):2561-2562. PubMed ID: 29945524
[No Abstract] [Full Text] [Related]
3. Comparing Modalities Using the National Cancer Database: Concerns With Rajyaguru et al.
Pollom EL; Feng M; Chang DT
J Clin Oncol; 2018 Aug; 36(24):2557. PubMed ID: 29945518
[No Abstract] [Full Text] [Related]
4. In reply to Huo et al.: Treating small hepatocellular carcinoma: Stereotactic body radiation therapy versus radiofrequency ablation.
Park S; Jung J; Cho B; Kim SY; Yun SC; Lim YS; Lee HC; Park J; Park JH; Kim JH; Yoon SM
J Gastroenterol Hepatol; 2020 Dec; 35(12):2293. PubMed ID: 32909286
[No Abstract] [Full Text] [Related]
5. Casual Causality: Does Radiofrequency Ablation Really Prolong Survival After Treatment of Localized Hepatocellular Carcinoma?
Wahl DR; Schipper MJ; Parikh ND; Owen D; Lawrence TS
J Clin Oncol; 2018 Aug; 36(24):2559-2560. PubMed ID: 29945526
[No Abstract] [Full Text] [Related]
6. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: No Way Out Without a Randomized Trial?
Fiorentino A; Alongi F
J Clin Oncol; 2018 Aug; 36(24):2558-2559. PubMed ID: 29945528
[No Abstract] [Full Text] [Related]
7. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Caution When Interpreting Observational Data.
Ohri N; Kabarriti R; Kaubisch A; Guha C
J Clin Oncol; 2018 Aug; 36(24):2558. PubMed ID: 29945527
[No Abstract] [Full Text] [Related]
8. Are Head-to-Head Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy Really Necessary for Localized Hepatocellular Carcinoma?
Sanuki N; Takeda A
J Clin Oncol; 2018 Aug; 36(24):2563-2564. PubMed ID: 29945522
[No Abstract] [Full Text] [Related]
9. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?
Shinde A; Jones BL; Chen YJ; Amini A
J Clin Oncol; 2018 Aug; 36(24):2566-2567. PubMed ID: 29945529
[No Abstract] [Full Text] [Related]
10. What Role Does Locally Ablative Stereotactic Body Radiotherapy Play Versus Radiofrequency Ablation in Localized Hepatocellular Carcinoma?
Kim N; Seong J
J Clin Oncol; 2018 Aug; 36(24):2560-2561. PubMed ID: 29945523
[No Abstract] [Full Text] [Related]
11. Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.
Smith GL; Das P; Herman JM; Koay EJ; Koong AC; Grossberg A; Ludmir E
J Clin Oncol; 2018 Aug; 36(24):2565-2566. PubMed ID: 29945520
[No Abstract] [Full Text] [Related]
12. In reply to: Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma.
Zhang H; Sun Y
Future Oncol; 2023 Feb; 19(4):289-290. PubMed ID: 37013832
[No Abstract] [Full Text] [Related]
13. In Reply to Slovak et al.
Jackson WC; Cuneo KC; Lawrence TS; Owen D
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):696-697. PubMed ID: 31162061
[No Abstract] [Full Text] [Related]
14. Letter: is microwave ablation superior to radiofrequency ablation for early stage hepatocellular carcinoma? Authors' reply.
Liu W; Li B; Yuan Y
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1326-1327. PubMed ID: 30488634
[No Abstract] [Full Text] [Related]
15. Reply to Erridge et al. 'Re: Gavriilidis et al., 'Survival following Redo Hepatectomy vs Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis''.
Gavriilidis P; Askari A; Azoulay D
HPB (Oxford); 2017 Sep; 19(9):832-833. PubMed ID: 28709725
[No Abstract] [Full Text] [Related]
16. Letter: microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria-Authors' reply.
Liu W; Li B; Yuan Y
Aliment Pharmacol Ther; 2018 Nov; 48(9):1027-1028. PubMed ID: 30318692
[No Abstract] [Full Text] [Related]
17. Letter: is microwave ablation superior to radiofrequency ablation for early-stage hepatocellular carcinoma?
Liao YY; Ge DX; Zhang XY
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1325-1326. PubMed ID: 30488621
[No Abstract] [Full Text] [Related]
18. Editorial on Machi et al. "long term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma".
Lencioni R
World J Surg; 2005 Nov; 29(11):1363. PubMed ID: 16222457
[No Abstract] [Full Text] [Related]
19. Reply to s. Bonovas et Al, s. Clement et Al, and j.L. Lund et Al.
Tsan YT; Lee CS; Ho WC; Lin MH; Wang JD; Chen PC
J Clin Oncol; 2013 Nov; 31(32):4162-4. PubMed ID: 24081943
[No Abstract] [Full Text] [Related]
20. Is Stereotactic Body Radiotherapy Better Than Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma?
Yang JF; Lo CH; Huang WY
J Clin Oncol; 2016 Aug; 34(23):2797. PubMed ID: 27325860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
